Clinical trials

The three toddlers, who have congenital deafness linked to mutations in the OTOF (otoferlin) gene, received intra-cochlear administration of the gene therapy. Image: RFBSIP/stock.adobe.com.

Clinical trials

Sensorion gives gene therapy to third deaf toddler; provides details of first Aus patient

December 27, 2024

Sensorion has provided gene therapy to two more toddlers with congenital deafness after the first child, an Australian infant, received...

From left, Professor Bronwyn Myers, director of the enAble Institute, and part of the HearChoice team with Associate Professor Melanie Ferguson and the Curtin University award. Image: Melanie Ferguson.

Clinical trials

Curtin University prototype HearChoice decision support app for consumers

by Helen Carter

December 13, 2024

A web-based app to help adults with hearing loss make informed choices about hearing healthcare has progressed to a beta...

Rinri’s first target has been the regeneration of auditory neurons which transmit signals from the cochlea to the brain via the auditory pathway. Image: Jitendra Jadhav/stock.adobe.com.

Clinical trials

Surgical method devised to deliver world first stem cell treatment for neural hearing loss

by Helen Carter

December 1, 2024

World first regenerative cell therapy to replace damaged sensory cells in the inner ear, aiming to restore hearing, is expected...

Sydney ENT surgeon Clinical Professor Catherine Birman OAM pictured in August 2024 at the Royal Prince Alfred Hospital's 40th anniversary celebrations of its first cochlear implant. Prof Birman performed the pioneering gene therapy transfer on the first patient, an Australian infant born with profound to severe hearing loss. Image: Royal Prince Alfred Hospital. Gene image: vegefox/stock.adobe.com.

Clinical trials

EXCLUSIVE: First Australian child to have gene therapy for deafness in pioneering trial

by Helen Carter

November 19, 2024

EXCLUSIVE: A young child has become the first in Australia to receive pioneering gene therapy for deafness in a groundbreaking...

Melbourne ENT surgeon Professor Stephen O’Leary pictured earlier this year with Victorian Health Minister Mary-Anne Thomas at the opening of The Royal Victorian Eye and Ear Hospital redevelopment. Image: The Royal Victorian Eye and Ear Hospital.

Clinical trials

Sensorion study reveals breakthrough drug therapy can prevent residual hearing loss in cochlear implant patients

by Helen Carter

November 19, 2024

Melbourne ENT surgeon Professor Stephen O’Leary has revealed encouraging results from a trial of cochlear implant patients who received drug...

The revolutionary EarGenie system to detect auditory responses in babies is expected in audiology practices soon. It is partly funded by the Passe & Williams Foundation. Image: The University of Melbourne.

Clinical trials

Passe & Williams Foundation – a legacy for good

by Helen Carter

November 19, 2024

Over the past 33 years, the Melbourne-based Passe & Williams Foundation has funded more than 400 research projects in Australia...

The sound processor, driver and sensor are fully implanted components. Image: Envoy Medical investor presentation July 2024.

Clinical trials

Envoy Medical receives FDA approval for trial of first fully implantable cochlear implant

by Helen Carter

November 9, 2024

America’s Food and Drug Administration (FDA) has approved a clinical trial of Envoy Medical’s Acclaim fully implanted cochlear implant, the...

Three of Australia's top audiology experts Professor Julia Sarant from the University of Melbourne, Professor Piers Dawes from the University of Queensland and Associate Professor Dona Jayakody from Ear Science Institute Australia discuss the evidence about hearing loss and dementia. Images: Julia Sarant, Piers Dawes and Dona Jayakody.

Clinical trials

Hearing loss, cognitive decline and dementia; the experts explain

by Helen Carter

November 4, 2024

The links between hearing impairment, cognitive decline and dementia are receiving much attention as studies point to an association. Other...

The protyope ClearDrum prosthetic eardrum made from material from silkworms. Image: ClearDrum.

Clinical trials

Ear Science Institute developing world first prosthetic eardrum from silkworm-spun silk

by Helen Carter

October 25, 2024

Ear Science Institute Australia is developing a world-first prosthetic eardrum based on silk fibroin biomaterial using silk spun from silkworms...

Initial results have shown that the new test can diagnose tinnitus with 78% accuracy and distinguish between mild and severe tinnitus with 87% accuracy. Image: The Bionics Institute.

Clinical trials

Bionics Institute trialling world first diagnostic tool to measure tinnitus

by Helen Carter

October 14, 2024

Researchers at the Bionics Institute in Melbourne have developed a world first test to objectively measure tinnitus with a brain...

NHMRC grants fund brain stimulation for tinnitus, and novel otitis media treatments

Clinical trials

Sensorion gives gene therapy to third deaf toddler; provides details of first Aus patient

Curtin University prototype HearChoice decision support app for consumers

Surgical method devised to deliver world first stem cell treatment for neural hearing loss

EXCLUSIVE: First Australian child to have gene therapy for deafness in pioneering trial

Sensorion study reveals breakthrough drug therapy can prevent residual hearing loss in cochlear implant patients

Passe & Williams Foundation – a legacy for good

Envoy Medical receives FDA approval for trial of first fully implantable cochlear implant

Hearing loss, cognitive decline and dementia; the experts explain

Ear Science Institute developing world first prosthetic eardrum from silkworm-spun silk

Bionics Institute trialling world first diagnostic tool to measure tinnitus

Join our newsletter

Subscribe to our newsletter

About Hearing Practitioner Australia

Popular Topics